Development of gynecomastia following initiation of bictegravir/emtricitabine/tenofovir alafenamide. [electronic resource]
Producer: 20200810Description: 380-382 p. digitalISSN:- 1758-1052
- Adenine -- adverse effects
- Adult
- Alanine
- Amides
- Anti-HIV Agents -- adverse effects
- Antiretroviral Therapy, Highly Active -- adverse effects
- CD4 Lymphocyte Count
- Drug Combinations
- Emtricitabine -- adverse effects
- Gynecomastia -- chemically induced
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Heterocyclic Compounds, 3-Ring
- Heterocyclic Compounds, 4 or More Rings -- adverse effects
- Humans
- Male
- Piperazines
- Pyridones
- Tenofovir -- analogs & derivatives
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.